Potential tariffs could impact the medical device industry, which relies on components sourced from other countries. This is a critical time to secure exemptions from these potential policies, and the medical device industry has an opportunity to do so by educating and influencing key decision-makers and stakeholders.

Educating and Amplifying the Significance of Medical Devices to Americans
Many Americans rely on medical devices. Educating lawmakers can help carve out exceptions from potential tariffs. Even if medical devices are not currently under attack from tariffs, now is the time to educate the Administration and Members of Congress about the benefits of medical devices to Americans and the significant impact that tariffs could cause. Tariffs on medical devices could result in the following negative effects on Americans:

• Cost of Healthcare Escalation: Taxing medical devices could lead to higher costs for Americans.
• Supply Chain Disruptions: Tariffs will disrupt the supply chain, which could lead to increased prices and an inability to respond to emergencies in the United States.
• Research and Development Impact: Research and development for the next generation could suffer.

Protecting the Medical Device Industry
Tariffs would negatively impact millions of Americans. We are in a critical moment for the medical device industry to educate key stakeholders, fight disinformation, and develop key alliances and advocates. Signal can work with you to develop strategies to achieve these goals including:

• Educating Key Decision-makers: It’s critical that the industry educates members of Congress and the administration about medical devices and how blanket tariffs would affect costs and hurt Americans. This demands media outreach, thought leadership, social media content, digital amplification, and advocacy efforts.
• Building and Nurturing Alliances: There is an opportunity to highlight the economic impact, especially through the stories of real people whose healthcare has been disrupted, weakened, or outright eliminated due to skyrocketing costs.

Ensuring this Critical Moment Doesn’t Pass the Industry By
If any of these ideas resonate with you, I would be happy to speak with you about how my team and I may be able to work together to tell the story of medical devices at this critical time.

Scott Lusk
Executive Vice President
slusk@signaldc.com